58 related articles for article (PubMed ID: 15344379)
1. The intracellular microenvironment in host cell-specific phosphorylation of SNT1 by the FGFR1 tyrosine kinase.
Jin CL; McKeehan K; Lambert D; Wang F
Shi Yan Sheng Wu Xue Bao; 2002 Sep; 35(3):184-90. PubMed ID: 15344379
[TBL] [Abstract][Full Text] [Related]
2. Cell- and receptor isotype-specific phosphorylation of SNT1 by fibroblast growth factor receptor tyrosine kinases.
Wang F
In Vitro Cell Dev Biol Anim; 2002 Mar; 38(3):178-83. PubMed ID: 12026167
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.
Feng S; Wang F; Matsubara A; Kan M; McKeehan WL
Cancer Res; 1997 Dec; 57(23):5369-78. PubMed ID: 9393762
[TBL] [Abstract][Full Text] [Related]
4. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 1 phosphotyrosine 766: molecular target for prevention of progression of prostate tumors to malignancy.
Wang F; McKeehan K; Yu C; McKeehan WL
Cancer Res; 2002 Mar; 62(6):1898-903. PubMed ID: 11912171
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2.
Matsubara A; Kan M; Feng S; McKeehan WL
Cancer Res; 1998 Apr; 58(7):1509-14. PubMed ID: 9537256
[TBL] [Abstract][Full Text] [Related]
7. Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia.
Wang F; McKeehan K; Yu C; Ittmann M; McKeehan WL
Prostate; 2004 Jan; 58(1):1-12. PubMed ID: 14673947
[TBL] [Abstract][Full Text] [Related]
8. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.
Wu Y; Chen Z; Ullrich A
Biol Chem; 2003 Aug; 384(8):1215-26. PubMed ID: 12974390
[TBL] [Abstract][Full Text] [Related]
9. Docking protein SNT1 is a critical mediator of fibroblast growth factor signaling during Xenopus embryonic development.
Akagi K; Kyun Park E; Mood K; Daar IO
Dev Dyn; 2002 Mar; 223(2):216-28. PubMed ID: 11836786
[TBL] [Abstract][Full Text] [Related]
10. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors.
Jin C; Wang F; Wu X; Yu C; Luo Y; McKeehan WL
Cancer Res; 2004 Jul; 64(13):4555-62. PubMed ID: 15231666
[TBL] [Abstract][Full Text] [Related]
11. A role for extracellular and transmembrane domains of Sef in Sef-mediated inhibition of FGF signaling.
Kovalenko D; Yang X; Chen PY; Nadeau RJ; Zubanova O; Pigeon K; Friesel R
Cell Signal; 2006 Nov; 18(11):1958-66. PubMed ID: 16603339
[TBL] [Abstract][Full Text] [Related]
12. [The role of human fibroblast growth factor receptor 1-IIIb isoform in proliferation of pancreatic ductal cells and its effects to mitogen-activated protein kinase].
Liu ZB; Yang YM; Qiao QL; Wan YL; Kornmann M; Huang YT
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2812-6. PubMed ID: 17200012
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor 1 (FGFR1) tyrosine phosphorylation regulates binding of FGFR substrate 2alpha (FRS2alpha) but not FRS2 to the receptor.
Zhang Y; McKeehan K; Lin Y; Zhang J; Wang F
Mol Endocrinol; 2008 Jan; 22(1):167-75. PubMed ID: 17901128
[TBL] [Abstract][Full Text] [Related]
14. Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells.
Wang C; Ke Y; Liu S; Pan S; Liu Z; Zhang H; Fan Z; Zhou C; Liu J; Wang F
J Biol Chem; 2018 Sep; 293(38):14839-14849. PubMed ID: 30093411
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
17. Agonist-induced formation of FGFR1 homodimers and signaling differ among members of the FGF family.
Romero-Fernandez W; Borroto-Escuela DO; Tarakanov AO; Mudó G; Narvaez M; Pérez-Alea M; Agnati LF; Ciruela F; Belluardo N; Fuxe K
Biochem Biophys Res Commun; 2011 Jun; 409(4):764-8. PubMed ID: 21621521
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic tyrosine kinase of malignant hemopathy targets the centrosome.
Delaval B; Létard S; Lelièvre H; Chevrier V; Daviet L; Dubreuil P; Birnbaum D
Cancer Res; 2005 Aug; 65(16):7231-40. PubMed ID: 16103074
[TBL] [Abstract][Full Text] [Related]
19. Critical role of FLRT1 phosphorylation in the interdependent regulation of FLRT1 function and FGF receptor signalling.
Wheldon LM; Haines BP; Rajappa R; Mason I; Rigby PW; Heath JK
PLoS One; 2010 Apr; 5(4):e10264. PubMed ID: 20421966
[TBL] [Abstract][Full Text] [Related]
20. Role of epithelial cell fibroblast growth factor receptor substrate 2alpha in prostate development, regeneration and tumorigenesis.
Zhang Y; Zhang J; Lin Y; Lan Y; Lin C; Xuan JW; Shen MM; McKeehan WL; Greenberg NM; Wang F
Development; 2008 Feb; 135(4):775-84. PubMed ID: 18184727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]